Real-Time News FIRE NOW SIP Calculators

Easy-to-understand Financial Insights
that build Wealth.

Suit Of Products

Explore Dzambhala Pro

Sun Pharma's LEQSELVI™ (Deuruxolitinib) Gets U.S. FDA Nod for Severe Alopecia Treatment

July 26, 2024, 5:15 a.m.

Sun Pharmaceutical Industries Limited has received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI™ (deuruxolitinib), an oral JAK inhibitor for treating severe alopecia…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala Pro.

SUNPHARMA Regulatory